short term trading - week starting 19th nov, page-65

A couple of names that may be interesting today.
NEU:
Successfully completed oral NNZ-2566 oral phase 1 safety study & files IND for Rett Syndrome. Phase 2 will be partly funded by the Rett Syndrome Foundation.
----
SDI:
10% increase in sales last quarter.
Large bid orders surfacing.
Obamacare should lend a helping hand to health care providers with operations in the US.
------
AAO changed name to EML (for anyone interested)